Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: A review of the literature

Annals of Hematology

Volumn 88, Issue 1, 2009, Pages 11-15

  Salama, A ^a   Rieke, M ^b   Kiesewetter, H ^a   von Depka, M ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Werlhof Institute for Haemostasis and Thrombosis   (Germany)

Author keywords

Bleeding; Hemorrhage; Hemostasis; ITP; rFVIIa; Thrombocytopenia

Indexed keywords

AMINOCAPROIC ACID; AZATHIOPRINE; CD20 ANTIBODY; CORTICOSTEROID; CYCLOSPORIN; DESMOPRESSIN; DEXAMETHASONE; FIBRIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RHESUS D ANTIBODY; STEROID; TACROLIMUS; TRANEXAMIC ACID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VINCRISTINE;

ABSENCE OF SIDE EFFECTS; AUTOIMMUNE THROMBOCYTOPENIA; BLEEDING; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; EMERGENCY TREATMENT; HEMOSTASIS; HUMAN; INCIDENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE DRUG DOSE; SPLENECTOMY; THROMBOCYTE COUNT;

EMERGENCY TREATMENT; FACTOR VIIA; HEMOPHILIA A; HEMOSTASIS; HEMOSTATICS; HUMANS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RECOMBINANT PROTEINS; REVIEW LITERATURE AS TOPIC;

EID: 57049155999     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0608-3     Document Type: Review

References (47)

1. Abrahm J, Ellman L (1976) Platelet transfusion in immune thrombocytopenic purpura. JAMA 236:1847 doi: 10.1001/jama.236.16.1847a
2. Aguilar C, Lucía JF (2007) Successful control of severe postoperative bleeding with recombinant factor VIIa in a case of refractory idiopathic thrombocytopenic purpura. Am J Hematol 82:246-247 doi: 10.1002/ajh.20728
3. Barnes C, Blanchette V, Canning P, Carcao M (2005) Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatment. Transfus Med 15:145-150 doi: 10.1111/j.0958-7578.2005.00564.x
4. Baumann MA, Menitove JE, Aster RH, Anderson T (1986) Urgent treatment of idiopathic thrombocytopenic purpura with single-dose gammaglobulin infusion followed by platelet transfusion. Ann Intern Med 104:808-809
5. Baxter MS, Schroeder WS, Cheng Y, Bernstein ZP (2006) Diminished response to recombinant factor VIIa in a patient with idiopathic thrombocytopenic purpura. Ann Pharmacother 40:2053-2058 doi: 10.1345/ aph.1H331
6. Bay A, Oner AF, Etlik O, Caksen H (2005) A case of immune thrombocytopenic purpura presenting with recurrent intracranial hemorrhage. Pediatr Int 47:109-111 doi: 10.1111/j.1442-200x.2005.02014.x
7. Blanchette V, Freedman J, Garvey B (1998) Management of chronic immune thrombocytopenic purpura in children and adults. Semin Hematol 35:36-51
8. Busani S, Marietta M, Pasetto A, Girardis M (2005) Use of recombinant factor VIIa in a thrombocytopenic patient with spontaneous intracerebral haemorrhage. Thromb Haemost 93:381-382
9. Bussel JB, Kimberly RP, Inman RD, Schulman I, Cunningham-Rundles C, Cheung N et al (1983) Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura. Blood 62:480-486
10. Carr JM, Kruskall MS, Kaye JA, Robinson SH (1986) Efficacy of platelet transfusions in immune thrombocytopenia. Am J Med 80:1051-1054 doi: 10.1016/0002-9343(86)90664-9
11. Chandramouli NB, Rodgers GM (2000) Prolonged immunoglobulin and platelet infusion for treatment of immune thrombocytopenia. Am J Hematol 65:85-86 doi: 10.1002/1096-8652(200009)65:1<85::AID-AJH17>3.0.CO;2-9
12. Cines DB, Blanchette VS (2002) Immune thrombocytopenic purpura. N Engl J Med 346:995-1008 doi: 10.1056/NEJMra010501
13. Cines DB, McMillan R (2005) Management of adult idiopathic thrombocytopenic purpura. Annu Rev Med 56:425-442 doi: 10.1146/ annurev.med.56.082103.104644
14. Crosby WH (1975) Editorial: Wet purpura, dry purpura. JAMA 232:744-745 doi: 10.1001/jama.232.7.744
15. Culic S (2002) Recombinant factor VIIa for refractive haemorrhage in autoimmune idiopathic thrombocytopenic purpura. Br J Haematol 120:909-910 doi: 10.1046/j.1365-2141.2003.04151_2.x
16. Frederiksen H, Schmidt K (1999) The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 94:909-913
17. Friederich PW, Henny CP, Messelink EJ, Geerdink MG, Keller T, Kurth KH et al (2003) Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: A double-blind placebo-controlled randomised trial. Lancet 361:201-205 doi: 10.1016/S0140-6736(03)12268-4
18. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ et al (1996) Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood 88:3-40
19. Gerotziafas GT, Zervas C, Gavrielidis G, Tokmaktsis A, Hatjiharissi E, Papaioannou M et al (2002) Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. Am J Hematol 69:219-222 doi: 10.1002/ajh.10056
20. Goodnough LT (2004) Experiences with recombinant human factor VIIa in patients with thrombocytopenia. Semin Hematol 41:25-29 doi: 10.1053/ j.seminhematol.2003.11.006
21. Hadacova I, Hoch J (2003) Activated factor VII as the perioperative guarrancy of splenectomy for severe form of corticoresistant ITP. Prakt Lek 83:695-696
22. Hoffman M, Monroe DM, Roberts HR (1998) Activated factor VII activates factors IX and X on the surface of activated platelets: Thoughts on the mechanism of action of high dose activated FVII. Blood Coagul Fibrinolysis 9:S61-S65
23. Imbach P, Barandun S, D'Apuzzo V, Baumgartner C, Hirt A, Morell A et al (1981) High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1:1228-1231 doi: 10.1016/ S0140-6736(81)92400-4
24. Ingerslev J, Holm M, Christiansen K, Knudsen L, Négrier C (1998) Levels of prothrombin activation peptide F1 + 2 in patients with bleeding tendency. Blood Coagul Fibrinolysis 9:S129-S134 doi: 10.1097/ 00001721-199803000-00003
25. Kiefel V, Santoso S, Kaufmann E, Mueller-Eckhardt C (1991) Autoantibodies against platelet glycoprotein lb/IX: A frequent finding in autoimmune thrombocytopenic purpura. Br J Haematol 79:256-262 doi: 10.1111/j.1365-2141.1991.tb04530.x
26. Klamroth R, Gottstein S, Landgraf H (2002) Successful use of recombinant factor VIIa to prevent bleeding during major surgery in a patient with severe immune thrombocytopenia. Blood 100:77b
27. Kristensen J, Killander A, Hippe E, Helleberg C, Ellegard J, Holm M et al (1996) Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 26:159-164
28. Kubisz P, Stasko J (2004) Recombinant activated factor VII in patients at high risk of bleeding. Hematology 9:317-332 doi: 10.1080/ 10245330400018581
29. Levi M, Peters M, Büller HR (2005) Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review. Crit Care Med 33:883-890 doi: 10.1097/01.CCM.0000159087.85970.38
30. McMillan R, Tani P, Millard F, Berchtold P, Renshaw L, Woods VL Jr (2005) Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood 70:1040-1045
31. McMillan R (1997) Therapy for adults with refractory chronic immune thrombocytopenic purpura. Ann Intern Med 126:307-314
32. Meyer O, Agaylan A, Bombard S, Kiesewetter H, Salama A (2006) A novel antigen-specific capture assay for the detection of platelet antibodies and HPA-1a phenotyping. Vox Sang 91:324-330 doi: 10.1111/ j.1423-0410.2006.00839.x
33. Minniti C, Weinthal J (2001) Use of recombinant activated factor VII (rFVIIa) in two children with idiopathic thrombocytopenic purpura (ITP). Blood 98:62b
34. Monroe DM, Hoffman M, Oliver JA, Roberts HR (1997) Platelet activity of high dose factor VIIa is independent of tissue factor. Br J Haematol 99:542-547 doi: 10.1046/j.1365-2141.1997.4463256.x
35. Morath C, Hoffmann T, Kirchhoff EM, Sis J, Zeier M, Scharf RE et al (2005) Acquired Glanzmann's thrombasthenia variant and immune thrombocytopenia in a renal transplant recipient receiving tacrolimus. Thromb Haemost 94:879-880
36. Portielje JEA, Westendorp RGJ, Kluin-Nelemans HC, Brand A (2001) Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 97:2549-2554 doi: 10.1182/blood.V97.9.2549
37. Provan D, Newland A (2002) Fifty years of idiopathic thrombocytopenic purpura (ITP): Management of refractory ITP in adults. Br J Haematol 118:933-944 doi: 10.1046/j.1365-2141.2002.03669.x
38. Rao LVM, Williams T, Rapaport SI (1996) Studies on the activation of factor VII bound to tissue factor. Blood 87:3738-3748
39. Roberts HR (1998) Clinical experience with activated factor VII: Focus on safety aspects. Blood Coagul Fibrinolysis 9:S115-S118
40. Serban M, Petrescu CAM, Jinca C, Mihalov D (2003) Evaluation of the rFVIIa efficacy in children's haemorrhages of different etiology. J Thromb Haemost 1(Suppl.):1144 doi: 10.1046/j.1538-7836.2003.00144.x
41. Van Leeuwen EF, van der Ven JT, Engelfriet CP, von dem Borne AE (1982) Specifity of autoantibodies in autoimmune thrombocytopenia. Blood 59:23-36
42. Vidarsson B, Onundarson PT (2000) Recombinant factor VIIa for bleeding in refractory thrombocytopenia. Thromb Haemost 83:634-635
43. Virchis A, Hughes C, Berney S (2004) Severe gastrointeral haemorrhage responding to recombinant factor VIIa in a Jehova's Witness with refractory immune thrombocytopenia. Hematol J 5:281-282 doi: 10.1038/ sj.thj.6200395
44. Vyhovs'ka II, Karol' IS, Fedak LM, Tsytsyk OI (2004) Use of recombinant activated factor VII (NovoSeven) in the treatment of a patient with idiopathic thrombocytopenic purpura complicated with subarachnoid and parenchimatous hemorrhage. Lik Sprava 7:77-81
45. Waddington DP, McAuley FT, Hanley JP, Summerfield GP (2002) The use of recombinant factor VIIa in a Jehovah's witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage. Br J Haematol 119:286-288 doi: 10.1046/j.1365-2141.2002.381113.x
46. Wróbel G, Dobaczewski G, Patkowski D, Sokół A, Grotthus E (2006) Experiences with recombinant activated factor VII in the treatment of severe refractory thrombocytopenia. Pediatr Blood Cancer 47:729-730 doi: 10.1002/pbc.21013
47. Yoneoka Y, Tokita K, Yamauchi JI, Takeda N, Ohta H, Shindo T (2004) Successful management for spontaneous intracranial haemorrhage under critical thrombocytopenia (platelets <1000/mm(3)) due to adolescence-onset idiopathic thrombocytopenic purpura. Acta Neurochir (Wien) 146:199-201 doi: 10.1007/s00701-003-0185-0